nodes	percent_of_prediction	percent_of_DWPC	metapath
Teniposide—CYP2C9—cardial valve—dilated cardiomyopathy	0.0799	0.283	CbGeAlD
Teniposide—Podofilox—TUBB—dilated cardiomyopathy	0.0486	1	CrCbGaD
Teniposide—NCOA1—cardiac ventricle—dilated cardiomyopathy	0.0361	0.128	CbGeAlD
Teniposide—NCOA1—myocardium—dilated cardiomyopathy	0.034	0.12	CbGeAlD
Teniposide—ABCC6—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.0261	0.0696	CbGpPWpGaD
Teniposide—NCOA3—cardiac ventricle—dilated cardiomyopathy	0.0252	0.089	CbGeAlD
Teniposide—NCOA1—heart—dilated cardiomyopathy	0.0237	0.0839	CbGeAlD
Teniposide—NCOA3—myocardium—dilated cardiomyopathy	0.0237	0.0837	CbGeAlD
Teniposide—Hypotensive—Furosemide—dilated cardiomyopathy	0.0226	0.0797	CcSEcCtD
Teniposide—Metabolic acidosis—Furosemide—dilated cardiomyopathy	0.0209	0.0736	CcSEcCtD
Teniposide—NCOA1—cardiac atrium—dilated cardiomyopathy	0.0203	0.0717	CbGeAlD
Teniposide—NCOA3—heart—dilated cardiomyopathy	0.0165	0.0584	CbGeAlD
Teniposide—NCOA1—YAP1- and WWTR1 (TAZ)-stimulated gene expression—NPPA—dilated cardiomyopathy	0.0152	0.0404	CbGpPWpGaD
Teniposide—NCOA3—PPARA activates gene expression—ANKRD1—dilated cardiomyopathy	0.0145	0.0386	CbGpPWpGaD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—ZBTB17—dilated cardiomyopathy	0.0144	0.0384	CbGpPWpGaD
Teniposide—NCOA3—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ANKRD1—dilated cardiomyopathy	0.0142	0.0378	CbGpPWpGaD
Teniposide—NCOA3—cardiac atrium—dilated cardiomyopathy	0.0141	0.05	CbGeAlD
Teniposide—NCOA1—PPARA activates gene expression—ANKRD1—dilated cardiomyopathy	0.012	0.0319	CbGpPWpGaD
Teniposide—NCOA1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ANKRD1—dilated cardiomyopathy	0.0117	0.0313	CbGpPWpGaD
Teniposide—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.00978	0.026	CbGpPWpGaD
Teniposide—TOP2A—Methyltestosterone—Spironolactone—dilated cardiomyopathy	0.0095	1	CbGdCrCtD
Teniposide—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.00916	0.0323	CcSEcCtD
Teniposide—NCOA1—RXR and RAR heterodimerization with other nuclear receptor—RPS6KB1—dilated cardiomyopathy	0.00892	0.0238	CbGpPWpGaD
Teniposide—NCOA1—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.00809	0.0215	CbGpPWpGaD
Teniposide—Alopecia—Spironolactone—dilated cardiomyopathy	0.00672	0.0237	CcSEcCtD
Teniposide—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00663	0.0234	CcSEcCtD
Teniposide—NCOA1—IL-6 signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00597	0.0159	CbGpPWpGaD
Teniposide—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00593	0.0209	CcSEcCtD
Teniposide—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00581	0.0205	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00575	0.0153	CbGpPWpGaD
Teniposide—Confusional state—Spironolactone—dilated cardiomyopathy	0.00545	0.0192	CcSEcCtD
Teniposide—NCOA1—IL-6 signaling pathway—RAC1—dilated cardiomyopathy	0.00539	0.0144	CbGpPWpGaD
Teniposide—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00529	0.0187	CcSEcCtD
Teniposide—TOP2A—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.00518	0.0138	CbGpPWpGaD
Teniposide—NCOA1—IL-6 signaling pathway—AGT—dilated cardiomyopathy	0.00515	0.0137	CbGpPWpGaD
Teniposide—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00514	0.0181	CcSEcCtD
Teniposide—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00497	0.0175	CcSEcCtD
Teniposide—ABCG2—heart—dilated cardiomyopathy	0.00484	0.0171	CbGeAlD
Teniposide—NCOA1—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00476	0.0127	CbGpPWpGaD
Teniposide—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00445	0.0157	CcSEcCtD
Teniposide—Sweating—Furosemide—dilated cardiomyopathy	0.00442	0.0156	CcSEcCtD
Teniposide—CYP2C9—heart—dilated cardiomyopathy	0.00442	0.0156	CbGeAlD
Teniposide—NCOA3—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00436	0.0116	CbGpPWpGaD
Teniposide—NCOA3—Transcriptional regulation of white adipocyte differentiation—CD36—dilated cardiomyopathy	0.00434	0.0116	CbGpPWpGaD
Teniposide—Urticaria—Spironolactone—dilated cardiomyopathy	0.00429	0.0151	CcSEcCtD
Teniposide—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00427	0.0151	CcSEcCtD
Teniposide—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00398	0.014	CcSEcCtD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.0039	0.0104	CbGpPWpGaD
Teniposide—NCOA1—Adipogenesis—LMNA—dilated cardiomyopathy	0.00388	0.0103	CbGpPWpGaD
Teniposide—Pruritus—Spironolactone—dilated cardiomyopathy	0.00382	0.0135	CcSEcCtD
Teniposide—NCOA1—Leptin signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00382	0.0102	CbGpPWpGaD
Teniposide—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00382	0.0135	CcSEcCtD
Teniposide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.0037	0.013	CcSEcCtD
Teniposide—Arrhythmia—Furosemide—dilated cardiomyopathy	0.0037	0.013	CcSEcCtD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—IL10—dilated cardiomyopathy	0.0037	0.00984	CbGpPWpGaD
Teniposide—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00368	0.013	CcSEcCtD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00366	0.00975	CbGpPWpGaD
Teniposide—NCOA3—Androgen receptor signaling pathway—RAC1—dilated cardiomyopathy	0.00364	0.0097	CbGpPWpGaD
Teniposide—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00363	0.0128	CcSEcCtD
Teniposide—NCOA1—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00361	0.00961	CbGpPWpGaD
Teniposide—NCOA1—Transcriptional regulation of white adipocyte differentiation—CD36—dilated cardiomyopathy	0.00359	0.00956	CbGpPWpGaD
Teniposide—NCOA1—RXR and RAR heterodimerization with other nuclear receptor—TNF—dilated cardiomyopathy	0.00349	0.0093	CbGpPWpGaD
Teniposide—NCOA1—Leptin signaling pathway—RAC1—dilated cardiomyopathy	0.00345	0.0092	CbGpPWpGaD
Teniposide—Vomiting—Spironolactone—dilated cardiomyopathy	0.00344	0.0121	CcSEcCtD
Teniposide—Rash—Spironolactone—dilated cardiomyopathy	0.00341	0.012	CcSEcCtD
Teniposide—Dermatitis—Spironolactone—dilated cardiomyopathy	0.0034	0.012	CcSEcCtD
Teniposide—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00339	0.012	CcSEcCtD
Teniposide—Headache—Spironolactone—dilated cardiomyopathy	0.00339	0.0119	CcSEcCtD
Teniposide—Anaemia—Furosemide—dilated cardiomyopathy	0.00333	0.0117	CcSEcCtD
Teniposide—Sweating—Lisinopril—dilated cardiomyopathy	0.00332	0.0117	CcSEcCtD
Teniposide—Agitation—Furosemide—dilated cardiomyopathy	0.00331	0.0117	CcSEcCtD
Teniposide—NCOA3—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.00326	0.00869	CbGpPWpGaD
Teniposide—Leukopenia—Furosemide—dilated cardiomyopathy	0.00323	0.0114	CcSEcCtD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00322	0.00858	CbGpPWpGaD
Teniposide—Nausea—Spironolactone—dilated cardiomyopathy	0.00321	0.0113	CcSEcCtD
Teniposide—NCOA3—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.00319	0.0085	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00303	0.00807	CbGpPWpGaD
Teniposide—ABCC6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00302	0.00804	CbGpPWpGaD
Teniposide—NCOA1—Androgen receptor signaling pathway—RAC1—dilated cardiomyopathy	0.00301	0.00802	CbGpPWpGaD
Teniposide—Confusional state—Furosemide—dilated cardiomyopathy	0.00297	0.0105	CcSEcCtD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—GJA1—dilated cardiomyopathy	0.00296	0.00788	CbGpPWpGaD
Teniposide—NCOA3—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.00294	0.00782	CbGpPWpGaD
Teniposide—ABCC6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00294	0.00782	CbGpPWpGaD
Teniposide—ABCC6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00294	0.00782	CbGpPWpGaD
Teniposide—Flushing—Lisinopril—dilated cardiomyopathy	0.00288	0.0102	CcSEcCtD
Teniposide—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00288	0.0102	CcSEcCtD
Teniposide—NCOA3—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.00288	0.00766	CbGpPWpGaD
Teniposide—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00284	0.01	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.00283	0.00755	CbGpPWpGaD
Teniposide—Anorexia—Furosemide—dilated cardiomyopathy	0.0028	0.00989	CcSEcCtD
Teniposide—Chills—Lisinopril—dilated cardiomyopathy	0.00279	0.00983	CcSEcCtD
Teniposide—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00277	0.00979	CcSEcCtD
Teniposide—Hypotension—Furosemide—dilated cardiomyopathy	0.00275	0.00969	CcSEcCtD
Teniposide—Alopecia—Lisinopril—dilated cardiomyopathy	0.00274	0.00968	CcSEcCtD
Teniposide—ABCC6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00273	0.00727	CbGpPWpGaD
Teniposide—NCOA1—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.0027	0.00719	CbGpPWpGaD
Teniposide—NCOA1—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.00266	0.00707	CbGpPWpGaD
Teniposide—NCOA1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.00264	0.00703	CbGpPWpGaD
Teniposide—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00256	0.00902	CcSEcCtD
Teniposide—Anaemia—Lisinopril—dilated cardiomyopathy	0.0025	0.00882	CcSEcCtD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—RPS6KB1—dilated cardiomyopathy	0.0025	0.00665	CbGpPWpGaD
Teniposide—NCOA1—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.00243	0.00647	CbGpPWpGaD
Teniposide—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00242	0.00855	CcSEcCtD
Teniposide—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00242	0.00854	CcSEcCtD
Teniposide—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.0024	0.00848	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	0.00239	0.00635	CbGpPWpGaD
Teniposide—NCOA1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.00238	0.00633	CbGpPWpGaD
Teniposide—Urticaria—Furosemide—dilated cardiomyopathy	0.00234	0.00824	CcSEcCtD
Teniposide—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00232	0.0082	CcSEcCtD
Teniposide—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00232	0.0082	CcSEcCtD
Teniposide—NCOA1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.00232	0.00619	CbGpPWpGaD
Teniposide—Chest pain—Lisinopril—dilated cardiomyopathy	0.0023	0.00812	CcSEcCtD
Teniposide—NCOA1—Leptin signaling pathway—RAF1—dilated cardiomyopathy	0.00229	0.0061	CbGpPWpGaD
Teniposide—NCOA1—Adipogenesis—FAS—dilated cardiomyopathy	0.00227	0.00604	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—RAC1—dilated cardiomyopathy	0.00226	0.00601	CbGpPWpGaD
Teniposide—Confusional state—Lisinopril—dilated cardiomyopathy	0.00222	0.00785	CcSEcCtD
Teniposide—NCOA1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.00221	0.00589	CbGpPWpGaD
Teniposide—Oedema—Lisinopril—dilated cardiomyopathy	0.00221	0.00778	CcSEcCtD
Teniposide—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.0022	0.00586	CbGpPWpGaD
Teniposide—Infection—Lisinopril—dilated cardiomyopathy	0.00219	0.00773	CcSEcCtD
Teniposide—NCOA1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00218	0.00581	CbGpPWpGaD
Teniposide—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00217	0.00764	CcSEcCtD
Teniposide—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00216	0.00762	CcSEcCtD
Teniposide—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00215	0.0076	CcSEcCtD
Teniposide—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00213	0.00753	CcSEcCtD
Teniposide—NCOA1—Adipogenesis—AGT—dilated cardiomyopathy	0.00213	0.00566	CbGpPWpGaD
Teniposide—NCOA1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00212	0.00565	CbGpPWpGaD
Teniposide—NCOA1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00212	0.00565	CbGpPWpGaD
Teniposide—Asthenia—Furosemide—dilated cardiomyopathy	0.00211	0.00744	CcSEcCtD
Teniposide—Anorexia—Lisinopril—dilated cardiomyopathy	0.0021	0.00742	CcSEcCtD
Teniposide—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.0021	0.00559	CbGpPWpGaD
Teniposide—Pruritus—Furosemide—dilated cardiomyopathy	0.00208	0.00734	CcSEcCtD
Teniposide—Hypotension—Lisinopril—dilated cardiomyopathy	0.00206	0.00727	CcSEcCtD
Teniposide—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00201	0.0071	CcSEcCtD
Teniposide—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.00198	0.00528	CbGpPWpGaD
Teniposide—NCOA1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00197	0.00526	CbGpPWpGaD
Teniposide—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00197	0.00694	CcSEcCtD
Teniposide—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00192	0.00677	CcSEcCtD
Teniposide—Vomiting—Furosemide—dilated cardiomyopathy	0.00187	0.0066	CcSEcCtD
Teniposide—Rash—Furosemide—dilated cardiomyopathy	0.00185	0.00654	CcSEcCtD
Teniposide—Dermatitis—Furosemide—dilated cardiomyopathy	0.00185	0.00654	CcSEcCtD
Teniposide—Headache—Furosemide—dilated cardiomyopathy	0.00184	0.0065	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—PSEN2—dilated cardiomyopathy	0.00184	0.0049	CbGpPWpGaD
Teniposide—NCOA1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.00182	0.00485	CbGpPWpGaD
Teniposide—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00182	0.00641	CcSEcCtD
Teniposide—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.0018	0.00637	CcSEcCtD
Teniposide—NCOA3—Transcriptional regulation of white adipocyte differentiation—TNF—dilated cardiomyopathy	0.00177	0.00472	CbGpPWpGaD
Teniposide—Urticaria—Lisinopril—dilated cardiomyopathy	0.00175	0.00618	CcSEcCtD
Teniposide—Nausea—Furosemide—dilated cardiomyopathy	0.00175	0.00616	CcSEcCtD
Teniposide—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00174	0.00615	CcSEcCtD
Teniposide—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00174	0.00615	CcSEcCtD
Teniposide—NCOA3—Metabolism—ANKRD1—dilated cardiomyopathy	0.00173	0.00462	CbGpPWpGaD
Teniposide—TOP2A—Gastric Cancer Network 2—EGFR—dilated cardiomyopathy	0.00169	0.0045	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—TUBB—dilated cardiomyopathy	0.00168	0.00448	CbGpPWpGaD
Teniposide—NCOA1—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.00167	0.00444	CbGpPWpGaD
Teniposide—NCOA3—Androgen receptor signaling pathway—EGFR—dilated cardiomyopathy	0.00166	0.00441	CbGpPWpGaD
Teniposide—NCOA1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.00164	0.00436	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—TAZ—dilated cardiomyopathy	0.00163	0.00434	CbGpPWpGaD
Teniposide—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00163	0.00574	CcSEcCtD
Teniposide—Asthenia—Lisinopril—dilated cardiomyopathy	0.00158	0.00559	CcSEcCtD
Teniposide—Pruritus—Lisinopril—dilated cardiomyopathy	0.00156	0.00551	CcSEcCtD
Teniposide—NCOA1—Developmental Biology—PSEN2—dilated cardiomyopathy	0.00152	0.00405	CbGpPWpGaD
Teniposide—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00151	0.00533	CcSEcCtD
Teniposide—TOP2A—Cell Cycle—TUBB—dilated cardiomyopathy	0.00151	0.00401	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—EMD—dilated cardiomyopathy	0.0015	0.004	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—RAF1—dilated cardiomyopathy	0.0015	0.00398	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—SDHA—dilated cardiomyopathy	0.00147	0.00393	CbGpPWpGaD
Teniposide—NCOA1—Transcriptional regulation of white adipocyte differentiation—TNF—dilated cardiomyopathy	0.00146	0.0039	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—ANKRD1—dilated cardiomyopathy	0.00143	0.00382	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—ALMS1—dilated cardiomyopathy	0.00141	0.00376	CbGpPWpGaD
Teniposide—Vomiting—Lisinopril—dilated cardiomyopathy	0.0014	0.00495	CcSEcCtD
Teniposide—Rash—Lisinopril—dilated cardiomyopathy	0.00139	0.00491	CcSEcCtD
Teniposide—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00139	0.0049	CcSEcCtD
Teniposide—Headache—Lisinopril—dilated cardiomyopathy	0.00138	0.00488	CcSEcCtD
Teniposide—NCOA1—Androgen receptor signaling pathway—EGFR—dilated cardiomyopathy	0.00137	0.00365	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—TAZ—dilated cardiomyopathy	0.00135	0.00359	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—EMD—dilated cardiomyopathy	0.00134	0.00357	CbGpPWpGaD
Teniposide—Nausea—Lisinopril—dilated cardiomyopathy	0.00131	0.00462	CcSEcCtD
Teniposide—NCOA1—Gene Expression—NR3C2—dilated cardiomyopathy	0.00128	0.00341	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—ALMS1—dilated cardiomyopathy	0.00126	0.00336	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—SDHA—dilated cardiomyopathy	0.00122	0.00325	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—ITGB1—dilated cardiomyopathy	0.00115	0.00306	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	0.00109	0.00289	CbGpPWpGaD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—RAF1—dilated cardiomyopathy	0.00108	0.00287	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—EGFR—dilated cardiomyopathy	0.00103	0.00273	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—CD36—dilated cardiomyopathy	0.000981	0.00261	CbGpPWpGaD
Teniposide—NCOA1—Adipogenesis—TNF—dilated cardiomyopathy	0.000964	0.00257	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000951	0.00253	CbGpPWpGaD
Teniposide—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000931	0.00248	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—RAC1—dilated cardiomyopathy	0.000925	0.00246	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000917	0.00244	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.0009	0.0024	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—TMPO—dilated cardiomyopathy	0.000892	0.00238	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000884	0.00235	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000876	0.00233	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000867	0.00231	CbGpPWpGaD
Teniposide—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000849	0.00226	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000849	0.00226	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—CD36—dilated cardiomyopathy	0.000811	0.00216	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—NPPA—dilated cardiomyopathy	0.000803	0.00214	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—TMPO—dilated cardiomyopathy	0.000798	0.00212	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000789	0.0021	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—RAC1—dilated cardiomyopathy	0.000765	0.00204	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000744	0.00198	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—LMNA—dilated cardiomyopathy	0.000733	0.00195	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000725	0.00193	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000705	0.00188	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000685	0.00183	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000685	0.00183	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—LMNA—dilated cardiomyopathy	0.000655	0.00174	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000653	0.00174	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000637	0.0017	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—RAF1—dilated cardiomyopathy	0.000613	0.00163	CbGpPWpGaD
Teniposide—ABCC6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000596	0.00159	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000576	0.00153	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000575	0.00153	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000542	0.00144	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000525	0.0014	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—RAF1—dilated cardiomyopathy	0.000507	0.00135	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000494	0.00132	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000463	0.00123	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	0.000435	0.00116	CbGpPWpGaD
Teniposide—NCOA1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000431	0.00115	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—EGFR—dilated cardiomyopathy	0.00042	0.00112	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—GPX1—dilated cardiomyopathy	0.000401	0.00107	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—TNF—dilated cardiomyopathy	0.0004	0.00107	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000394	0.00105	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	0.000394	0.00105	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—CD36—dilated cardiomyopathy	0.00039	0.00104	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000375	0.001	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—AGT—dilated cardiomyopathy	0.000351	0.000936	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—EGFR—dilated cardiomyopathy	0.000348	0.000926	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	0.000332	0.000884	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—GPX1—dilated cardiomyopathy	0.000331	0.000882	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—TNF—dilated cardiomyopathy	0.000331	0.000882	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—CD36—dilated cardiomyopathy	0.000323	0.000859	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	0.000312	0.000831	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—AGT—dilated cardiomyopathy	0.000291	0.000774	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	0.000282	0.000751	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	0.000257	0.000683	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	0.000241	0.000642	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	0.000234	0.000623	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	0.00022	0.000586	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	0.000218	0.000581	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	0.000199	0.00053	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000154	0.000411	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000145	0.000386	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000139	0.00037	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000133	0.000354	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	0.000131	0.000349	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.00013	0.000345	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000121	0.000323	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000118	0.000315	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000117	0.000311	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	0.000107	0.000285	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000106	0.000283	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—CD36—dilated cardiomyopathy	0.000104	0.000277	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—AGT—dilated cardiomyopathy	9.38e-05	0.00025	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	7.67e-05	0.000204	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	7.47e-05	0.000199	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	6.72e-05	0.000179	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	5.93e-05	0.000158	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	5.77e-05	0.000154	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	5.4e-05	0.000144	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	5.26e-05	0.00014	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	5.2e-05	0.000138	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	4.74e-05	0.000126	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	3.56e-05	9.49e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	3.47e-05	9.24e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	3.12e-05	8.32e-05	CbGpPWpGaD
